[Efficacy of Tranexamic Acid to decrease perioperative bleeding in primary total reverse arthroplasty].

dc.contributor.authorR B Palmieri-Bouchan
dc.contributor.authorV H Aguirre-Rodríguez
dc.contributor.authorL E Salinas-Vela
dc.contributor.authorMI Encalada-Díaz
dc.contributor.authorFernando Suárez González
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T18:20:19Z
dc.date.available2026-03-22T18:20:19Z
dc.date.issued2021
dc.description.abstractThere is a tendency to have less PO bleeding in patients undergoing primary reverse arthroplasty with the use of ATXM and a lower PO blood transfusion requirement.
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/33634631
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/69522
dc.language.isoen
dc.publisherNational Institutes of Health
dc.relation.ispartofPubMed
dc.sourceUniversidad La Salle
dc.subjectMedicine
dc.subjectTranexamic acid
dc.subjectPerioperative
dc.subjectHematocrit
dc.subjectArthroplasty
dc.subjectSurgery
dc.subjectAnesthesia
dc.subjectRotator cuff
dc.subjectHemoglobin
dc.subjectBlood transfusion
dc.title[Efficacy of Tranexamic Acid to decrease perioperative bleeding in primary total reverse arthroplasty].
dc.typearticle

Files